UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.332

Sortiert nach

Tumorassoziierte venöse Thromboembolie – Pathogenese, Diagnose, Prävention und Therapie

Best practice onkologie, 2020-10, Vol.15 (10), p.448-455

Riess, H.

2020

Volltextzugriff (PDF)

PolyQ-expanded ataxin-3 protein levels in peripheral blood mononuclear cells correlate with clinical parameters in SCA3: a pilot study

Journal of neurology, 2021-04, Vol.268 (4), p.1304-1315

2021

Volltextzugriff (PDF)

Hyperthermia in combined treatment of cancer

The lancet oncology, 2002-08, Vol.3 (8), p.487-497

2002

Volltextzugriff (PDF)

α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study

British journal of cancer, 2014-11, Vol.111 (10), p.1917-1923

2014

Volltextzugriff (PDF)

Primary pharmacological prevention of thromboembolic events in ambulatory patients with advanced pancreatic cancer treated with chemotherapy?

Deutsche medizinische Wochenschrift (1946), 2013-10, Vol.138 (41), p.2084

2013

Volltextzugriff (PDF)

Conventional amphotericin B elicits markers of immunogenic cell death on leukemic blasts, mediates immunostimulatory effects on phagocytic cells, and synergizes with PD-L1 blockade

Oncoimmunology, 2022-12, Vol.11 (1), p.2068109-2068109

2022

Volltextzugriff (PDF)

Anticoagulant treatment of patients (pts) with cancer associated thromboembolism (CAT) in Germany: Real world data from a 4 million people sample generated by insurance captured data

Annals of oncology, 2018-10, Vol.29, p.viii569-viii569

2018

Volltextzugriff (PDF)

Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion

Annals of oncology, 2011-03, Vol.22 (3), p.524-535

2011

Volltextzugriff (PDF)

A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial

Annals of oncology, 2015-05, Vol.26 (5), p.921-927

2015

Volltextzugriff (PDF)

Germline findings in patients with advanced malignancies screened with paired blood–tumour testing for personalised treatment approaches

European journal of cancer (1990), 2023-01, Vol.179, p.48-55

2023

Volltextzugriff (PDF)

Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban

Clinical research in cardiology, 2013-06, Vol.102 (6), p.399-412

2013

Volltextzugriff (PDF)

Effect of Anti‐CD 20 Antibody Rituximab in Patients with Post‐Transplant Lymphoproliferative Disorder (PTLD)

American journal of transplantation, 2005-12, Vol.5 (12), p.2901-2906

2005

Volltextzugriff (PDF)

Women's beliefs about male circumcision, HIV prevention, and sexual behaviors in Kisumu, Kenya

PloS one, 2014-05, Vol.9 (5), p.e97748-e97748

2014

Volltextzugriff (PDF)

SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study

Annals of oncology, 2014-05, Vol.25 (5), p.1025-1032

2014

Volltextzugriff (PDF)

Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine – Results from the CONKO-001 trial

European journal of cancer (1990), 2015-08, Vol.51 (12), p.1546-1554

2015

Volltextzugriff (PDF)

A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial

EBioMedicine, 2021-04, Vol.66, p.103327-103327, Article 103327

2021

Volltextzugriff (PDF)

"When I was circumcised I was taught certain things": risk compensation and protective sexual behavior among circumcised men in Kisumu, Kenya

PloS one, 2010-08, Vol.5 (8), p.e12366-e12366

2010

Volltextzugriff (PDF)

Zielgerichtete Antiangiogenese mit Bevacizumab und vaskuläre Ereignisse

Der Onkologe, 2013-11, Vol.19 (11), p.983-992

2013

Volltextzugriff (PDF)

International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20‐Positive B Cell PTLD: Clues From the PTLD‐1 Trial

American journal of transplantation, 2015-04, Vol.15 (4), p.1091-1100

2015

Volltextzugriff (PDF)

CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer – Final results

European journal of cancer (1990), 2020-10, Vol.138, p.172-181

2020

Volltextzugriff (PDF)

Serum-free light chains adjusted for renal function are a potential biomarker for post-transplant lymphoproliferative disorders

Annals of hematology, 2019-03, Vol.98 (3), p.625-632

2019

Volltextzugriff (PDF)

A Comprehensive Analysis of the Cellular and EBV‐Specific MicroRNAome in Primary CNS PTLD Identifies Different Patterns Among EBV‐Associated Tumors

American journal of transplantation, 2014-11, Vol.14 (11), p.2577-2587

2014

Volltextzugriff (PDF)

Health-related quality of life (HRQoL) in patients with early-stage pancreatic cancer (ESPC) receiving adjuvant or neoadjuvant chemotherapy (A/NAC): A systematic literature review (SLR)

Annals of oncology, 2018-10, Vol.29, p.viii253-viii253

2018

Volltextzugriff (PDF)

Analysis of patient screening in the phase III, international, randomized, open-label APACT trial

Annals of oncology, 2019-07, Vol.30, p.iv110-iv110

2019

Volltextzugriff (PDF)

Corrections to “SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study”

Annals of oncology, 2017-11, Vol.28 (11), p.2900-2900

2017

Volltextzugriff (PDF)

1 – 25 von 1.332

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.055)
Mit Volltextzugriff
(1.104)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Tumorassoziierte venöse Thromboembolie – Pathogenese, Diagnose, Prävention und Therapie

PolyQ-expanded ataxin-3 protein levels in peripheral blood mononuclear cells correlate with clinical parameters in SCA3: a pilot study

Hyperthermia in combined treatment of cancer

α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study

Primary pharmacological prevention of thromboembolic events in ambulatory patients with advanced pancreatic cancer treated with chemotherapy?

Conventional amphotericin B elicits markers of immunogenic cell death on leukemic blasts, mediates immunostimulatory effects on phagocytic cells, and synergizes with PD-L1 blockade

Anticoagulant treatment of patients (pts) with cancer associated thromboembolism (CAT) in Germany: Real world data from a 4 million people sample generated by insurance captured data

Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion

A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial

Germline findings in patients with advanced malignancies screened with paired blood–tumour testing for personalised treatment approaches

Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban

Effect of Anti‐CD 20 Antibody Rituximab in Patients with Post‐Transplant Lymphoproliferative Disorder (PTLD)

Women's beliefs about male circumcision, HIV prevention, and sexual behaviors in Kisumu, Kenya

SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study

Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine – Results from the CONKO-001 trial

A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial

"When I was circumcised I was taught certain things": risk compensation and protective sexual behavior among circumcised men in Kisumu, Kenya

Zielgerichtete Antiangiogenese mit Bevacizumab und vaskuläre Ereignisse

International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20‐Positive B Cell PTLD: Clues From the PTLD‐1 Trial

CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer – Final results

Serum-free light chains adjusted for renal function are a potential biomarker for post-transplant lymphoproliferative disorders

A Comprehensive Analysis of the Cellular and EBV‐Specific MicroRNAome in Primary CNS PTLD Identifies Different Patterns Among EBV‐Associated Tumors

Health-related quality of life (HRQoL) in patients with early-stage pancreatic cancer (ESPC) receiving adjuvant or neoadjuvant chemotherapy (A/NAC): A systematic literature review (SLR)

Analysis of patient screening in the phase III, international, randomized, open-label APACT trial

Corrections to “SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study”

Suchergebnisse filtern